Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P70
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 8.12% |
| Q3 2025 | -20.28% |
| Q2 2025 | 36.60% |
| Q1 2025 | 32.51% |
| Q4 2024 | -41.95% |
| Q3 2024 | 37.56% |
| Q2 2024 | -13515.54% |
| Q1 2024 | -103.61% |
| Q4 2023 | 362.16% |
| Q3 2023 | -160.04% |
| Q2 2023 | 269.74% |
| Q1 2023 | 89.79% |
| Q4 2022 | -15.37% |
| Q3 2022 | 7.28% |
| Q2 2022 | -14.34% |
| Q1 2022 | -43.87% |
| Q4 2021 | -35.37% |
| Q3 2021 | -59.92% |
| Q2 2021 | -3.20% |
| Q1 2021 | -42.25% |
| Q4 2020 | 0.00% |